RSS Feeds
Search

Companies

Companies

Displaying 1..1 of 1 - per page
Order by
Aphton
Aphton is an oncology drug development company. More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Metastatic Pancreatic Cancer - Pipeline Review, Q3 2011
Jul 2011 - 321 pages - $500
Pancreatic Cancer - Pipeline Assessment and Market Forecasts to 2017
Nov 2010 - 65 pages - $2,000
Innovations in Oncology Diagnostics
Oct 2009 - 141 pages - $3,835
Pancreatic Cancer Therapy Area Pipeline Report
Nov 2010 - 538 pages - $1,495
Pancreatic Cancer - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
AMG479 (Pancreatic Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 26 pages - $2,000
GV1001 (Pancreatic Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 25 pages - $2,000
Sutent (Pancreatic Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 32 pages - $2,000
Masitinib (Pancreatic Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 34 pages - $2,000
Tarceva (Pancreatic cancer) – Analysis and Forecasts to 2020
Oct 2011 - 34 pages - $2,000
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Human diagnostics del
Therapeutic target
Oncology del
Pancreatic cancer del

Browse By

Therapeutic target
Adenocarcinoma
Pancreatic cancer exocrine
Geographic location
Africa
Asia
Australia/New Zealand
Central America
Europe
Near & Far East
North America
South America

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us